Clinical Trial

Tensi+ for Treating Overactive Bladder

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for treating patients suffering from OAB symptoms urinary frequency, urgency, with or without urge urinary incontinence.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-21.
Trial Details
NCT Number NCT07300904
Lead Sponsor Stimuli Technology
Conditions Overactive Bladder (OAB)
Enrollment 60 participants
Start Date 2026-05
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-28